Vericel logo

Vericel Share Price (NASDAQ: VCEL)

$36.34

0.45

(1.25%)

Last updated on

Check the interactive Vericel Stock chart to analyse performance

Vericel stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$36.17
    Today's High:$36.75

    Day's Volatility :1.58%

  • 52 Weeks Low:$33.09
    52 Weeks High:$63.00

    52 Weeks Volatility :47.48%

Vericel Stock Returns

PeriodVericel CorporationSector (Health Care)Index (Russel 2000)
3 Months
-10.24%
3.6%
0.0%
6 Months
-26.65%
-7.7%
0.0%
1 Year
-25.95%
-12.6%
0.0%
3 Years
47.86%
9.5%
-4.7%

Vericel Corporation Key Stats

Check Vericel key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$35.89
Open
$36.19
Today's High
$36.75
Today's Low
$36.17
Market Capitalization
$1.8B
Today's Volume
$331.1K
52 Week High
$63.0
52 Week Low
$33.09
Revenue TTM
$249.1M
EBITDA
$9.5M
Earnings Per Share (EPS)
$0.14
PE Ratio
256.36
Profit Margin
2.85%
Quarterly Earnings Growth YOY
0.48%
Return On Equity TTM
2.59%

Stock Returns calculator for Vericel Stock including INR - Dollar returns

The Vericel stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vericel investment value today

Current value as on today

₹75,642

Returns

₹24,358

(-24.36%)

Returns from Vericel Stock

₹29,642 (-29.64%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Vericel Stock

-71%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Vericel Stock from India on INDmoney has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vericel Corporation

  • Name

    Holdings %

  • BlackRock Inc

    15.82%

  • Vanguard Group Inc

    7.06%

  • Brown Capital Management, LLC

    5.57%

  • Conestoga Capital Advisors, LLC

    4.88%

  • State Street Corp

    4.83%

  • FMR Inc

    4.56%

Analyst Recommendation on Vericel Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Vericel(by analysts ranked 0 to 5 stars)

Vericel Share Price Target

What analysts predicted

Upside of 48.25%

Target:

$53.88

Current:

$36.34

Vericel share price target is $53.88, a slight Upside of 48.25% compared to current price of $36.34 as per analysts' prediction.

Vericel Stock Insights

  • Price Movement

    In the last 1 month, VCEL stock has moved down by -10.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 52.59M → 63.24M (in $), with an average increase of 16.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -11.24M → -553.0K (in $), with an average increase of 1933.6% per quarter
  • VCEL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 99.6%
  • VCEL vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 72.2%
  • Price to Sales

    ForVCEL every $1 of sales, investors are willing to pay $7.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Vericel Corporation Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$237.2M
↑ 20.1%
Net Income
$10.4M
↓ 425.64%
Net Profit Margin
4.37%
↑ 5.98%

Vericel Technicals Summary

Sell

Neutral

Buy

Vericel is currently in a neutral trading position according to technical analysis indicators.

Vericel Corporation Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Vericel Corporation logo
1.92%
-26.65%
-25.95%
47.86%
128.25%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Vericel Corporation

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Organization
Vericel
Employees
357
CEO
Mr. Dominick C. Colangelo Esq.
Industry
Health Technology

Key Management of Vericel Corporation

NameTitle
Mr. Dominick C. Colangelo Esq.
CEO, President & Director
Mr. Joseph Anthony Mara Jr.
CFO & Treasurer
Mr. Michael Halpin
Chief Operating Officer
Mr. Sean C. Flynn
Chief Legal Officer
Ms. Karen Mahoney
Chief Human Resources Officer
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.
Chief Medical Officer
Mr. Jonathan D. Siegal
Principal Accounting Officer, VP & Corporate Controller
Mr. Eric Burns
Vice President of Finance & Investor Relations
Mr. Roland DeAngelis
Chief Marketing Officer
Mr. Patrick J. Fowler
Senior Vice President of Corporate Development & Strategy

Important FAQs about investing in VCEL Stock from India :

What is Vericel share price today?

Vericel share price today is $36.34 as on at the close of the market. Vericel share today touched a day high of $36.75 and a low of $36.17.

What is the 52 week high and 52 week low for Vericel share?

Vericel share touched a 52 week high of $63.00 and a 52 week low of $33.09. Vericel stock price today i.e. is closed at $36.34, lower by 42.32% versus the 52 week high.

How to invest in Vericel Stock (VCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vericel on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Shares that will get you 0.0413 shares as per Vericel share price of $36.34 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vericel Stock (VCEL) from India?

Indian investors can start investing in Vericel (VCEL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Vericel stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Vericel share’s latest price of $36.34 as on August 30, 2025 at 1:29 am IST, you will get 0.2752 shares of Vericel. Learn more about fractional shares .

What are the returns that Vericel has given to Indian investors in the last 5 years?

Vericel stock has given 128.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?